$8.42
0.253.06%
Last update: Oct 9, 4:00 PM
Exagen Inc
XGNNASDAQ
Exagen (XGN) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Exagen (XGN) last issued guidance on August 4, 2026 for fiscal year 2026. The company guided revenue in the range of $72M - $75M for the period.
Compared to prior guidance, Exagen raised its revenue forecast from a prior range of $70M - $73M.
Exagen has issued 16 guidance updates between November 14, 2022 and August 4, 2026. During this period, the company raised its outlook 6 times and lowered it 6 times, providing investors with insight into management's evolving expectations.
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.19 | $-0.25 | $-0.20 | $-0.15 |
| Actual | $-0.13 | $-0.17 | $-0.20 | $-0.19 |
| Surprise | +31.6% | +32.0% | 0.00% | -26.7% |
| Revenue | ||||
| Estimate | $17.8M | $16.4M | $16.5M | $17.0M |
| Actual | $19.9M | $17.3M | $16.6M | $17.2M |
| Surprise | +11.7% | +5.29% | +0.85% | +1.44% |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.17 | $-0.17 | $-0.18 | $-0.12 |
| Revenue | ||||
| Consensus | $18.3M | $18.3M | — | — |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q2 | Aug 4, 2026 | $-0.13 | $-0.19 | 31.6 % |
| Q1 | May 11, 2026 | $-0.17 | $-0.25 | 32.0 % |
| Q4 | Mar 10, 2026 | $-0.20 | $-0.20 | 0.00 % |
| Q3 | Nov 4, 2025 | $-0.19 | $-0.15 | -26.7 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q2 | Aug 4, 2026 | $19.94M | $17.85M | 11.7 % |
| Q1 | May 11, 2026 | $17.31M | $16.44M | 5.29 % |
| Q4 | Mar 10, 2026 | $16.63M | $16.49M | 0.85 % |
| Q3 | Nov 4, 2025 | $17.24M | $17.00M | 1.44 % |
